Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
International Archives of Allergy and Immunology|December 1, 2001
The role of interleukin 10 in the regulation of allergic immune responsesI Bellinghausen, J Knop, J Saloga
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 7, 2006
[Mechanisms of specific immunotherapy]I Bellinghausen, J Knop, J Saloga
The Journal of Allergy and Clinical Immunology|May 16, 2000
Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donorsI Bellinghausen, U Brand, J Knop, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 21, 2006
Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their inductionI Bellinghausen, B König, I Böttcher, et al.
The Journal of Allergy and Clinical Immunology|February 9, 1999
Signals involved in the early TH1/TH2 polarization of an immune response depending on the type of antigenI Bellinghausen, U Brand, A H Enk, et al.
The Journal of Allergy and Clinical Immunology|February 9, 1999
Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cellsM Pierkes, I Bellinghausen, T Hultsch, et al.
The Journal of Investigative Dermatology|October 1, 1996
Epidermal cells enhance interleukin 4 and immunoglobulin E production after stimulation with protein allergenI Bellinghausen, A H Enk, M Mohamadzadeh, et al.
European Journal of Immunology|May 1, 1997
Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjectsI Bellinghausen, G Metz, A H Enk, et al.
Immunology|July 11, 1998
Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivoJ Saloga, A H Enk, D Becker, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2001
Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cellsI Bellinghausen, U Brand, K Steinbrink, et al.
Pageof 23